• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

曲霉过敏原的分子生物学

Molecular biology of Aspergillus allergens.

作者信息

Banerjee Banani, Kurup Viswanath P

机构信息

Allergy-Immunology Division, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.

出版信息

Front Biosci. 2003 Jan 1;8:s128-39. doi: 10.2741/982.

DOI:10.2741/982
PMID:12456370
Abstract

Allergic Bronchopulmonary Aspergillosis (ABPA) is a severe respiratory disease caused by the fungus Aspergillus fumigatus (Af). It occurs as secondary complication mostly in patients with atopy and cystic fibrosis. The standardized and well-characterized allergens are essential for the immunodiagnosis of ABPA as well as for understanding the pathophysiology of the disease. Molecular cloning was resorted to obtain purified Af allergens for such studies. Currently, twenty-two recombinant Af allergens have been identified and characterized and several of these can be used as standardized allergens in in vitro and in vivo diagnosis of ABPA. The knowledge of primary, secondary, and tertiary structures of these allergens may facilitate the identification of immunodominant T and B cell epitopes and may be used to unravel the structure function relationship of these allergens. Such findings may open up novel avenues in the immune modulatory therapy and other effective intervention of the disease.

摘要

变应性支气管肺曲霉病(ABPA)是一种由烟曲霉(Af)引起的严重呼吸系统疾病。它主要作为继发性并发症发生于特应性和囊性纤维化患者中。标准化且特征明确的变应原对于ABPA的免疫诊断以及理解该疾病的病理生理学至关重要。为了进行此类研究,采用分子克隆方法来获得纯化的Af变应原。目前,已鉴定和表征了22种重组Af变应原,其中几种可作为标准化变应原用于ABPA的体外和体内诊断。了解这些变应原的一级、二级和三级结构可能有助于鉴定免疫显性T和B细胞表位,并可用于阐明这些变应原的结构功能关系。这些发现可能为该疾病的免疫调节治疗和其他有效干预开辟新途径。

相似文献

1
Molecular biology of Aspergillus allergens.曲霉过敏原的分子生物学
Front Biosci. 2003 Jan 1;8:s128-39. doi: 10.2741/982.
2
Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy.患有变应性支气管肺曲霉病或曲霉过敏的囊性纤维化患者对重组烟曲霉变应原的特异性IgE识别。
Eur J Immunol. 1998 Apr;28(4):1155-60. doi: 10.1002/(SICI)1521-4141(199804)28:04<1155::AID-IMMU1155>3.0.CO;2-6.
3
IgE antibody to Aspergillus fumigatus recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis.患有变应性支气管肺曲霉病的囊性纤维化患者中针对烟曲霉重组变应原的IgE抗体
Allergy. 2004 Feb;59(2):198-203. doi: 10.1046/j.1398-9995.2003.00310.x.
4
Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization.烟曲霉致敏的哮喘患者对两种重组烟曲霉变应原的皮肤试验反应性有助于将变应性支气管肺曲霉病与真菌致敏进行诊断区分。
J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):601-7. doi: 10.1016/s0091-6749(99)70330-1.
5
Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary aspergillosis (ABPA).烟曲霉变应原Asp f 16的克隆与表达,该变应原在变应性支气管肺曲霉病(ABPA)中介导体液免疫和细胞介导免疫。
Clin Exp Allergy. 2001 May;31(5):761-70. doi: 10.1046/j.1365-2222.2001.01076.x.
6
Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications.重组烟曲霉过敏原:从核苷酸序列到临床应用
Int Arch Allergy Immunol. 1998 Feb;115(2):99-114. doi: 10.1159/000023889.
7
Molecular characterization of aspergillus fumigatus allergens.烟曲霉过敏原的分子特征
Indian J Chest Dis Allied Sci. 2000 Oct-Dec;42(4):239-48.
8
Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis.用于诊断变应性支气管肺曲霉病的疾病特异性重组变应原。
Int Immunol. 1998 Aug;10(8):1211-6. doi: 10.1093/intimm/10.8.1211.
9
Intracutaneous tests with recombinant allergens in cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus allergy.对患有变应性支气管肺曲霉病和曲霉过敏的囊性纤维化患者进行重组变应原皮内试验。
Am J Respir Crit Care Med. 2002 Apr 1;165(7):916-21. doi: 10.1164/ajrccm.165.7.2109008.
10
Allergic bronchopulmonary aspergillosis' diagnosis remains a challenge.变应性支气管肺曲霉病的诊断仍然是一项挑战。
Respir Med. 2007 Nov;101(11):2352-7. doi: 10.1016/j.rmed.2007.06.018. Epub 2007 Aug 3.

引用本文的文献

1
Assessment of genetically modified soybean GMB151 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2018-153).根据欧盟法规(EC)No 1829/2003(申请编号EFSA-GMO-NL-2018-153)对转基因大豆GMB151进行食品和饲料用途评估。
EFSA J. 2021 Apr 19;19(4):e06424. doi: 10.2903/j.efsa.2021.6424. eCollection 2021 Apr.
2
Healthy human T-Cell Responses to Aspergillus fumigatus antigens.健康人类对烟曲霉抗原的 T 细胞反应。
PLoS One. 2010 Feb 17;5(2):e9036. doi: 10.1371/journal.pone.0009036.
3
Molecular and immunological characterization of allergens from the entomopathogenic fungus Beauveria bassiana.
球孢白僵菌昆虫病原真菌变应原的分子和免疫学特征
Clin Mol Allergy. 2006 Sep 22;4:12. doi: 10.1186/1476-7961-4-12.
4
Tryptophan residue is essential for immunoreactivity of a diagnostically relevant peptide epitope of A. fumigatus.色氨酸残基对于烟曲霉诊断相关肽表位的免疫反应性至关重要。
Mol Cell Biochem. 2005 Jul;275(1-2):223-31. doi: 10.1007/s11010-005-2056-x.
5
Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.针对来自烟曲霉f16过敏原的人类白细胞抗原I类限制性表位产生细胞毒性T细胞应答。
Clin Exp Immunol. 2005 Apr;140(1):81-91. doi: 10.1111/j.1365-2249.2005.02738.x.
6
Generation of Th1 T cell responses directed to a HLA Class II restricted epitope from the Aspergillus f16 allergen.针对来自烟曲霉f16变应原的HLA II类限制性表位产生Th1 T细胞应答。
Clin Exp Immunol. 2005 Feb;139(2):257-67. doi: 10.1111/j.1365-2249.2005.02699.x.
7
Allergens of the entomopathogenic fungus Beauveria bassiana.昆虫病原真菌球孢白僵菌的变应原。
Clin Mol Allergy. 2005 Jan 11;3(1):1. doi: 10.1186/1476-7961-3-1.